Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM. Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med 2008;168:826-831. Data from the Group Health Atrial ...

Please provide your email address to receive an email when new articles are posted on . Adults with overweight or obesity, but not type 2 diabetes, lost 14.9% of their body weight after 46 weeks of ...

Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD among postmenopausal women with T2D and osteoporosis. Romosozumab followed by alendronate treatment ...

Compared with alendronate, teriparatide was associated with significantly greater pain reduction and better quality of life among postmenopausal women with osteoporosis. Teriparatide has a favorable ...

Please provide your email address to receive an email when new articles are posted on . Adults treated with prednisolone and alendronate had reduced risk for hip fracture, major osteoporotic fracture, ...

Alendronate and teriparatide both improve BMD in osteoporotic patients, and it seems logical that combination therapy with both agents would have a higher efficacy than either of them alone. When this ...

Statin pills for patient with high cholesterol Decrease in bone mass is common in the first 6 to 12 months after kidney transplantation. Long-term use of alendronate, a bisphosphonate, may slow bone ...

Objective: To develop a method that estimates and compares the antifracture efficacy [relative risk reduction (RRR) and number needed to treat (NNT)] of various antiresorptive agents when fracture ...

Radius Health announced new data from the ACTIVExtend study evaluating fracture risk reductions in postmenopausal women receiving Tymlos (abaloparatide) injection. The full findings were presented at ...

Giving 10mg per day of the bisphosphate drug alendronate to women after their menopause can help prevent loss of bone mass, reducing their risk of fractures, a Cochrane Review has found. This finding ...

child pills in hand Alendronate treatment is well-tolerated and improved bone mineral density (BMD) with no safety concerns in children and adolescents with perinatally acquired HIV. Alendronate ...

The long-term safety of bisphosphonates for the treatment of osteoporosis has been questioned. Two case series have suggested a link between prolonged bisphosphonate therapy and atypical fractures. In ...